Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 27 entries
Sorted by: Best Match Show Resources per page
Anticholinergic syndrome induced by toxic plants.

World journal of emergency medicine

Soulaidopoulos S, Sinakos E, Dimopoulou D, Vettas C, Cholongitas E, Garyfallos A.
PMID: 29123609
World J Emerg Med. 2017;8(4):297-301. doi: 10.5847/wjem.j.1920-8642.2017.04.009.

No abstract available.

Cite
Soulaidopoulos S, Sinakos E, Dimopoulou D, et al. Anticholinergic syndrome induced by toxic plants. World J Emerg Med. 2017;8(4):297-301doi: 10.5847/wjem.j.1920-8642.2017.04.009.
Soulaidopoulos, S., Sinakos, E., Dimopoulou, D., Vettas, C., Cholongitas, E., & Garyfallos, A. (2017). Anticholinergic syndrome induced by toxic plants. World journal of emergency medicine, 8(4), 297-301. https://doi.org/10.5847/wjem.j.1920-8642.2017.04.009
Soulaidopoulos, Stergios, et al. "Anticholinergic syndrome induced by toxic plants." World journal of emergency medicine vol. 8,4 (2017): 297-301. doi: https://doi.org/10.5847/wjem.j.1920-8642.2017.04.009
Soulaidopoulos S, Sinakos E, Dimopoulou D, Vettas C, Cholongitas E, Garyfallos A. Anticholinergic syndrome induced by toxic plants. World J Emerg Med. 2017;8(4):297-301. doi: 10.5847/wjem.j.1920-8642.2017.04.009. PMID: 29123609; PMCID: PMC5675972.
Copy Download .nbib Format: NLM
Coronary vasospasm inducing rhythm disturbances: a case report study.

Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese

Soulaidopoulos S, Vogiatzi G, Vaina S, Latsios G, Vavuranakis M, Tousoulis D, Tsioufis K.
PMID: 34166788
Hellenic J Cardiol. 2021 Jun 21; doi: 10.1016/j.hjc.2021.06.006. Epub 2021 Jun 21.

No abstract available.

Cite
Soulaidopoulos S, Vogiatzi G, Vaina S, et al. Coronary vasospasm inducing rhythm disturbances: a case report study. Hellenic J Cardiol. 2021;doi: 10.1016/j.hjc.2021.06.006.
Soulaidopoulos, S., Vogiatzi, G., Vaina, S., Latsios, G., Vavuranakis, M., Tousoulis, D., & Tsioufis, K. (2021). Coronary vasospasm inducing rhythm disturbances: a case report study. Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese, . https://doi.org/10.1016/j.hjc.2021.06.006
Soulaidopoulos, Stergios, et al. "Coronary vasospasm inducing rhythm disturbances: a case report study." Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese vol. (2021). doi: https://doi.org/10.1016/j.hjc.2021.06.006
Soulaidopoulos S, Vogiatzi G, Vaina S, Latsios G, Vavuranakis M, Tousoulis D, Tsioufis K. Coronary vasospasm inducing rhythm disturbances: a case report study. Hellenic J Cardiol. 2021 Jun 21; doi: 10.1016/j.hjc.2021.06.006. Epub 2021 Jun 21. PMID: 34166788.
Copy Download .nbib Format: NLM
Association Between Uric Acid and Worsening Peripheral Microangiopathy in Systemic Sclerosis.

Frontiers in medicine

Pagkopoulou E, Soulaidopoulos S, Triantafyllidou E, Malliari A, Kitas GD, Garyfallos A, Dimitroulas T.
PMID: 35004786
Front Med (Lausanne). 2021 Dec 24;8:806925. doi: 10.3389/fmed.2021.806925. eCollection 2021.

No abstract available.

Cite
Pagkopoulou E, Soulaidopoulos S, Triantafyllidou E, et al. Association Between Uric Acid and Worsening Peripheral Microangiopathy in Systemic Sclerosis. Front Med (Lausanne). 2021;8:806925doi: 10.3389/fmed.2021.806925.
Pagkopoulou, E., Soulaidopoulos, S., Triantafyllidou, E., Malliari, A., Kitas, G. D., Garyfallos, A., & Dimitroulas, T. (2021). Association Between Uric Acid and Worsening Peripheral Microangiopathy in Systemic Sclerosis. Frontiers in medicine, 8806925. https://doi.org/10.3389/fmed.2021.806925
Pagkopoulou, Eleni, et al. "Association Between Uric Acid and Worsening Peripheral Microangiopathy in Systemic Sclerosis." Frontiers in medicine vol. 8 (2021): 806925. doi: https://doi.org/10.3389/fmed.2021.806925
Pagkopoulou E, Soulaidopoulos S, Triantafyllidou E, Malliari A, Kitas GD, Garyfallos A, Dimitroulas T. Association Between Uric Acid and Worsening Peripheral Microangiopathy in Systemic Sclerosis. Front Med (Lausanne). 2021 Dec 24;8:806925. doi: 10.3389/fmed.2021.806925. eCollection 2021. PMID: 35004786; PMCID: PMC8739221.
Copy Download .nbib Format: NLM
Syncope associated with supraventricular tachycardia: Diagnostic role of implantable loop recorders.

Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc

Soulaidopoulos S, Arsenos P, Doundoulakis I, Tsiachris D, Antoniou CK, Dilaveris P, Fragakis N, Sotiriadou M, Sideris S, Kordalis A, Laina A, Tousoulis D, Tsioufis K, Gatzoulis KA.
PMID: 33955102
Ann Noninvasive Electrocardiol. 2021 Sep;26(5):e12850. doi: 10.1111/anec.12850. Epub 2021 May 06.

Syncope represents a relatively uncommon symptom of supraventricular tachycardia (SVT). It is likely that an impaired autonomic vasomotor response to the hemodynamic stress of tachycardia is the determinant of hemodynamic changes leading to cerebral hypoperfusion and syncope. In this...

Cite
Soulaidopoulos S, Arsenos P, Doundoulakis I, et al. Syncope associated with supraventricular tachycardia: Diagnostic role of implantable loop recorders. Ann Noninvasive Electrocardiol. 2021;26(5):e12850doi: 10.1111/anec.12850.
Soulaidopoulos, S., Arsenos, P., Doundoulakis, I., Tsiachris, D., Antoniou, C. K., Dilaveris, P., Fragakis, N., Sotiriadou, M., Sideris, S., Kordalis, A., Laina, A., Tousoulis, D., Tsioufis, K., & Gatzoulis, K. A. (2021). Syncope associated with supraventricular tachycardia: Diagnostic role of implantable loop recorders. Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc, 26(5), e12850. https://doi.org/10.1111/anec.12850
Soulaidopoulos, Stergios, et al. "Syncope associated with supraventricular tachycardia: Diagnostic role of implantable loop recorders." Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc vol. 26,5 (2021): e12850. doi: https://doi.org/10.1111/anec.12850
Soulaidopoulos S, Arsenos P, Doundoulakis I, Tsiachris D, Antoniou CK, Dilaveris P, Fragakis N, Sotiriadou M, Sideris S, Kordalis A, Laina A, Tousoulis D, Tsioufis K, Gatzoulis KA. Syncope associated with supraventricular tachycardia: Diagnostic role of implantable loop recorders. Ann Noninvasive Electrocardiol. 2021 Sep;26(5):e12850. doi: 10.1111/anec.12850. Epub 2021 May 06. PMID: 33955102; PMCID: PMC8411760.
Copy Download .nbib Format: NLM
Evaluating the Safety and Tolerability of Azilsartan Medoxomil alone or in combination with Chlorthalidone in the Management of Hypertension: A Systematic Review.

Current hypertension reviews

Katsi V, Michalakeas C, Soulaidopoulos S, Antonopoulos AS, Vlachopoulos C, Tousoulis D, Tsioufis K.
PMID: 33438552
Curr Hypertens Rev. 2021 Jan 12; doi: 10.2174/1573402117666210112144505. Epub 2021 Jan 12.

BACKGROUND AND AIM: Azilsartan medoxomil (AZM) is the newest representative in the class of angiotensin receptor blockers. Azilsartan medoxomil in combination with the older diuretic chlorthalidone (CLD) in fixed-doses of AZM/CLD 40/12.5 mg and 40/25 mg has been approved...

Cite
Katsi V, Michalakeas C, Soulaidopoulos S, et al. Evaluating the Safety and Tolerability of Azilsartan Medoxomil alone or in combination with Chlorthalidone in the Management of Hypertension: A Systematic Review. Curr Hypertens Rev. 2021;doi: 10.2174/1573402117666210112144505.
Katsi, V., Michalakeas, C., Soulaidopoulos, S., Antonopoulos, A. S., Vlachopoulos, C., Tousoulis, D., & Tsioufis, K. (2021). Evaluating the Safety and Tolerability of Azilsartan Medoxomil alone or in combination with Chlorthalidone in the Management of Hypertension: A Systematic Review. Current hypertension reviews, . https://doi.org/10.2174/1573402117666210112144505
Katsi, Vasiliki, et al. "Evaluating the Safety and Tolerability of Azilsartan Medoxomil alone or in combination with Chlorthalidone in the Management of Hypertension: A Systematic Review." Current hypertension reviews vol. (2021). doi: https://doi.org/10.2174/1573402117666210112144505
Katsi V, Michalakeas C, Soulaidopoulos S, Antonopoulos AS, Vlachopoulos C, Tousoulis D, Tsioufis K. Evaluating the Safety and Tolerability of Azilsartan Medoxomil alone or in combination with Chlorthalidone in the Management of Hypertension: A Systematic Review. Curr Hypertens Rev. 2021 Jan 12; doi: 10.2174/1573402117666210112144505. Epub 2021 Jan 12. PMID: 33438552.
Copy Download .nbib Format: NLM
Time to reconsider risk stratification in dilated cardiomyopathy.

Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese

Laina A, Gatzoulis KA, Soulaidopoulos S, Arsenos P, Doundoulakis I, Tsiachris D, Sideris S, Kordalis A, Tousoulis D, Tsioufis K.
PMID: 33839282
Hellenic J Cardiol. 2021 Sep-Oct;62(5):392-393. doi: 10.1016/j.hjc.2021.03.008. Epub 2021 Apr 08.

No abstract available.

Cite
Laina A, Gatzoulis KA, Soulaidopoulos S, et al. Time to reconsider risk stratification in dilated cardiomyopathy. Hellenic J Cardiol. 2021;62(5):392-393doi: 10.1016/j.hjc.2021.03.008.
Laina, A., Gatzoulis, K. A., Soulaidopoulos, S., Arsenos, P., Doundoulakis, I., Tsiachris, D., Sideris, S., Kordalis, A., Tousoulis, D., & Tsioufis, K. (2021). Time to reconsider risk stratification in dilated cardiomyopathy. Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese, 62(5), 392-393. https://doi.org/10.1016/j.hjc.2021.03.008
Laina, A, et al. "Time to reconsider risk stratification in dilated cardiomyopathy." Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese vol. 62,5 (2021): 392-393. doi: https://doi.org/10.1016/j.hjc.2021.03.008
Laina A, Gatzoulis KA, Soulaidopoulos S, Arsenos P, Doundoulakis I, Tsiachris D, Sideris S, Kordalis A, Tousoulis D, Tsioufis K. Time to reconsider risk stratification in dilated cardiomyopathy. Hellenic J Cardiol. 2021 Sep-Oct;62(5):392-393. doi: 10.1016/j.hjc.2021.03.008. Epub 2021 Apr 08. PMID: 33839282.
Copy Download .nbib Format: NLM
Evaluating the Safety and Tolerability of Azilsartan Medoxomil Alone or in Combination With Chlorthalidone in the Management of Hypertension: A Systematic Review.

Current hypertension reviews

Katsi V, Michalakeas C, Soulaidopoulos S, Antonopoulos AS, Vlachopoulos C, Tousoulis D, Tsioufis K.
PMID: 33438552
Curr Hypertens Rev. 2021;17(3):217-227. doi: 10.2174/1573402117666210112144505.

BACKGROUND: Azilsartan medoxomil (AZM) is the newest representative in the class of angiotensin receptor blockers. Azilsartan medoxomil in combination with the older diuretic chlorthalidone (CLD) in fixed-doses of AZM/CLD 40/12.5 mg and 40/25 mg has been approved by the...

Cite
Katsi V, Michalakeas C, Soulaidopoulos S, et al. Evaluating the Safety and Tolerability of Azilsartan Medoxomil Alone or in Combination With Chlorthalidone in the Management of Hypertension: A Systematic Review. Curr Hypertens Rev. 2021;17(3):217-227doi: 10.2174/1573402117666210112144505.
Katsi, V., Michalakeas, C., Soulaidopoulos, S., Antonopoulos, A. S., Vlachopoulos, C., Tousoulis, D., & Tsioufis, K. (2021). Evaluating the Safety and Tolerability of Azilsartan Medoxomil Alone or in Combination With Chlorthalidone in the Management of Hypertension: A Systematic Review. Current hypertension reviews, 17(3), 217-227. https://doi.org/10.2174/1573402117666210112144505
Katsi, Vasiliki, et al. "Evaluating the Safety and Tolerability of Azilsartan Medoxomil Alone or in Combination With Chlorthalidone in the Management of Hypertension: A Systematic Review." Current hypertension reviews vol. 17,3 (2021): 217-227. doi: https://doi.org/10.2174/1573402117666210112144505
Katsi V, Michalakeas C, Soulaidopoulos S, Antonopoulos AS, Vlachopoulos C, Tousoulis D, Tsioufis K. Evaluating the Safety and Tolerability of Azilsartan Medoxomil Alone or in Combination With Chlorthalidone in the Management of Hypertension: A Systematic Review. Curr Hypertens Rev. 2021;17(3):217-227. doi: 10.2174/1573402117666210112144505. PMID: 33438552.
Copy Download .nbib Format: NLM
High serum ferritin is associated with worse outcome of patients with decompensated cirrhosis.

Annals of gastroenterology

Oikonomou T, Goulis I, Soulaidopoulos S, Karasmani A, Doumtsis P, Tsioni K, Mandala E, Akriviadis E, Cholongitas E.
PMID: 28243043
Ann Gastroenterol. 2017;30(2):217-224. doi: 10.20524/aog.2016.0112. Epub 2016 Dec 08.

BACKGROUND: Studies in patients with decompensated cirrhosis showed a correlation between serum ferritin levels and patients' prognosis. Besides, red blood cell distribution width (RDW) and mean platelet volume (MPV) have been associated with the severity of hepatic function. The...

Cite
Oikonomou T, Goulis I, Soulaidopoulos S, et al. High serum ferritin is associated with worse outcome of patients with decompensated cirrhosis. Ann Gastroenterol. 2016;30(2):217-224doi: 10.20524/aog.2016.0112.
Oikonomou, T., Goulis, I., Soulaidopoulos, S., Karasmani, A., Doumtsis, P., Tsioni, K., Mandala, E., Akriviadis, E., & Cholongitas, E. (2017). High serum ferritin is associated with worse outcome of patients with decompensated cirrhosis. Annals of gastroenterology, 30(2), 217-224. https://doi.org/10.20524/aog.2016.0112
Oikonomou, Theodora, et al. "High serum ferritin is associated with worse outcome of patients with decompensated cirrhosis." Annals of gastroenterology vol. 30,2 (2017): 217-224. doi: https://doi.org/10.20524/aog.2016.0112
Oikonomou T, Goulis I, Soulaidopoulos S, Karasmani A, Doumtsis P, Tsioni K, Mandala E, Akriviadis E, Cholongitas E. High serum ferritin is associated with worse outcome of patients with decompensated cirrhosis. Ann Gastroenterol. 2017;30(2):217-224. doi: 10.20524/aog.2016.0112. Epub 2016 Dec 08. PMID: 28243043; PMCID: PMC5320035.
Copy Download .nbib Format: NLM
Mobile phones and applications in the management of patients with arterial hypertension.

American journal of cardiovascular disease

Michalakeas C, Katsi V, Soulaidopoulos S, Dilaveris P, Vrachatis D, Lekakis I, Vlachopoulos C, Tsioufis K, Tousoulis D.
PMID: 33224593
Am J Cardiovasc Dis. 2020 Oct 15;10(4):419-431. eCollection 2020.

The use of mobile health (mHealth) in the field of medicine is constantly evolving and advancing. Arterial hypertension, a major modifiable cardiovascular risk factor with a high prevalence in the general population, frequently remains underdiagnosed and thus untreated. Furthermore,...

Cite
Michalakeas C, Katsi V, Soulaidopoulos S, et al. Mobile phones and applications in the management of patients with arterial hypertension. Am J Cardiovasc Dis. 2020;10(4):419-431
Michalakeas, C., Katsi, V., Soulaidopoulos, S., Dilaveris, P., Vrachatis, D., Lekakis, I., Vlachopoulos, C., Tsioufis, K., & Tousoulis, D. (2020). Mobile phones and applications in the management of patients with arterial hypertension. American journal of cardiovascular disease, 10(4), 419-431.
Michalakeas, Christos, et al. "Mobile phones and applications in the management of patients with arterial hypertension." American journal of cardiovascular disease vol. 10,4 (2020): 419-431.
Michalakeas C, Katsi V, Soulaidopoulos S, Dilaveris P, Vrachatis D, Lekakis I, Vlachopoulos C, Tsioufis K, Tousoulis D. Mobile phones and applications in the management of patients with arterial hypertension. Am J Cardiovasc Dis. 2020 Oct 15;10(4):419-431. eCollection 2020. PMID: 33224593; PMCID: PMC7675159.
Copy Download .nbib Format: NLM
Evaluating the Safety and Tolerability of Azilsartan Medoxomil Alone or in Combination With Chlorthalidone in the Management of Hypertension: A Systematic Review.

Current hypertension reviews

Katsi V, Michalakeas C, Soulaidopoulos S, Antonopoulos AS, Vlachopoulos C, Tousoulis D, Tsioufis K.
PMID: 33438552
Curr Hypertens Rev. 2021;17(3):217-227. doi: 10.2174/1573402117666210112144505.

BACKGROUND: Azilsartan medoxomil (AZM) is the newest representative in the class of angiotensin receptor blockers. Azilsartan medoxomil in combination with the older diuretic chlorthalidone (CLD) in fixed-doses of AZM/CLD 40/12.5 mg and 40/25 mg has been approved by the...

Cite
Katsi V, Michalakeas C, Soulaidopoulos S, et al. Evaluating the Safety and Tolerability of Azilsartan Medoxomil Alone or in Combination With Chlorthalidone in the Management of Hypertension: A Systematic Review. Curr Hypertens Rev. 2021;17(3):217-227doi: 10.2174/1573402117666210112144505.
Katsi, V., Michalakeas, C., Soulaidopoulos, S., Antonopoulos, A. S., Vlachopoulos, C., Tousoulis, D., & Tsioufis, K. (2021). Evaluating the Safety and Tolerability of Azilsartan Medoxomil Alone or in Combination With Chlorthalidone in the Management of Hypertension: A Systematic Review. Current hypertension reviews, 17(3), 217-227. https://doi.org/10.2174/1573402117666210112144505
Katsi, Vasiliki, et al. "Evaluating the Safety and Tolerability of Azilsartan Medoxomil Alone or in Combination With Chlorthalidone in the Management of Hypertension: A Systematic Review." Current hypertension reviews vol. 17,3 (2021): 217-227. doi: https://doi.org/10.2174/1573402117666210112144505
Katsi V, Michalakeas C, Soulaidopoulos S, Antonopoulos AS, Vlachopoulos C, Tousoulis D, Tsioufis K. Evaluating the Safety and Tolerability of Azilsartan Medoxomil Alone or in Combination With Chlorthalidone in the Management of Hypertension: A Systematic Review. Curr Hypertens Rev. 2021;17(3):217-227. doi: 10.2174/1573402117666210112144505. PMID: 33438552.
Copy Download .nbib Format: NLM
Atrial High-Rate Episodes in Patients with Devices Without a History of Atrial Fibrillation: a Systematic Review and Meta-analysis.

Cardiovascular drugs and therapy

Doundoulakis I, Gavriilaki M, Tsiachris D, Arsenos P, Antoniou CK, Dimou S, Soulaidopoulos S, Farmakis I, Akrivos E, Stoiloudis P, Notas K, Kimiskidis VK, Giannakoulas G, Paraskevaidis S, Gatzoulis KA, Tsioufis K.
PMID: 34089429
Cardiovasc Drugs Ther. 2021 Jun 05; doi: 10.1007/s10557-021-07209-8. Epub 2021 Jun 05.

PURPOSE: Atrial high-rate episodes (AHREs) recorded with cardiac implantable electronic devices (CIEDs) have been associated with the development of clinical atrial fibrillation (AF) and increase in stroke and death risk. We sought to perform a systematic review with a...

Cite
Doundoulakis I, Gavriilaki M, Tsiachris D, et al. Atrial High-Rate Episodes in Patients with Devices Without a History of Atrial Fibrillation: a Systematic Review and Meta-analysis. Cardiovasc Drugs Ther. 2021;doi: 10.1007/s10557-021-07209-8.
Doundoulakis, I., Gavriilaki, M., Tsiachris, D., Arsenos, P., Antoniou, C. K., Dimou, S., Soulaidopoulos, S., Farmakis, I., Akrivos, E., Stoiloudis, P., Notas, K., Kimiskidis, V. K., Giannakoulas, G., Paraskevaidis, S., Gatzoulis, K. A., & Tsioufis, K. (2021). Atrial High-Rate Episodes in Patients with Devices Without a History of Atrial Fibrillation: a Systematic Review and Meta-analysis. Cardiovascular drugs and therapy, . https://doi.org/10.1007/s10557-021-07209-8
Doundoulakis, Ioannis, et al. "Atrial High-Rate Episodes in Patients with Devices Without a History of Atrial Fibrillation: a Systematic Review and Meta-analysis." Cardiovascular drugs and therapy vol. (2021). doi: https://doi.org/10.1007/s10557-021-07209-8
Doundoulakis I, Gavriilaki M, Tsiachris D, Arsenos P, Antoniou CK, Dimou S, Soulaidopoulos S, Farmakis I, Akrivos E, Stoiloudis P, Notas K, Kimiskidis VK, Giannakoulas G, Paraskevaidis S, Gatzoulis KA, Tsioufis K. Atrial High-Rate Episodes in Patients with Devices Without a History of Atrial Fibrillation: a Systematic Review and Meta-analysis. Cardiovasc Drugs Ther. 2021 Jun 05; doi: 10.1007/s10557-021-07209-8. Epub 2021 Jun 05. PMID: 34089429.
Copy Download .nbib Format: NLM
Acute necrotizing pancreatitis after chemoembolization for hepatocellular.

Hippokratia

Soulaidopoulos S, Chalevas P, Cholongitas E.
PMID: 27895456
Hippokratia. 2016 Jan-Mar;20(1):95.

No abstract available.

Cite
Soulaidopoulos S, Chalevas P, Cholongitas E. Acute necrotizing pancreatitis after chemoembolization for hepatocellular. Hippokratia. 2016;20(1):95
Soulaidopoulos, S., Chalevas, P., & Cholongitas, E. (2016). Acute necrotizing pancreatitis after chemoembolization for hepatocellular. Hippokratia, 20(1), 95.
Soulaidopoulos, S, et al. "Acute necrotizing pancreatitis after chemoembolization for hepatocellular." Hippokratia vol. 20,1 (2016): 95.
Soulaidopoulos S, Chalevas P, Cholongitas E. Acute necrotizing pancreatitis after chemoembolization for hepatocellular. Hippokratia. 2016 Jan-Mar;20(1):95. PMID: 27895456; PMCID: PMC5074412.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 27 entries